Dihexa

Also known as: PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

Cognitive Enhancement

Preclinical

Dihexa is an exceptionally potent synthetic nootropic peptide that is reported to be approximately 7 orders of magnitude more potent than BDNF at promoting synaptogenesis. It was developed from angiotensin IV and is primarily studied for its ability to reverse cognitive deficits, promote neuroregeneration, and enhance memory consolidation.

Regulatory & Approval Status

Not FDA Approved

Dihexa research is limited to preclinical studies; there are no published human clinical trials and it is not approved by the FDA.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.